Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS
· Delayed Price · Currency is USD
0.640
+0.140 (28.00%)
At close: Mar 9, 2026
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $2.62 million as of March 9, 2026. Its market cap has decreased by -96.65% in one year.
Market Cap
2.62M
Enterprise Value
57.43M
Revenue
3.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.64
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from 142.02M to 2.62M, a decrease of -98.16%. That is a compound annual growth rate of -33.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sorrento Therapeutics | 2.61M |
| ProtoKinetix | 2.73M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| Galera Therapeutics | 3.02M |
| LakeShore Biopharma | 2.27M |
| ZyVersa Therapeutics | 2.19M |
| Burzynski Research Institute | 3.29M |